P
INSM icon

Pitcairn’s Insmed INSM Stock Holding History

Pitcairn’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,379
Closed -$631K – 272
2025
Q3 		$631K Sell
4,379
-721
-14% -$88.3K 0.05% 295
2025
Q2 		$513K Sell
5,100
-835
-14% -$63.8K 0.03% 400
2025
Q1 		$453K Sell
5,935
-85
-1% -$6.5K 0.03% 450
2024
Q4 		$416K Sell
6,020
-59
-1% -$4.25K 0.02% 481
2024
Q3 		$444K Sell
6,079
-1,279
-17% -$94.4K 0.03% 477
2024
Q2 		$493K Buy
+7,358
New +$285K 0.03% 448

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Pitcairn's INSM Position: Q4 2025 in Review

Pitcairn sold out of Insmed (INSM) in Q4 2025, closing a stake of 4,379 shares — an estimated $631K sold.

Pitcairn first reported a position in INSM in Q2 2024 and held it in 6 quarters. The position peaked at $631K in Q3 2025. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Pitcairn reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 4,379 Insmed shares in Q4 2025, an estimated $631K.
  • Pitcairn first reported a position in Insmed in Q2 2024 and held it in 6 quarters.
  • Pitcairn's Insmed position peaked at $631K in Q3 2025.
  • 677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.